These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 686825

  • 21. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
    Morison WL, Wimberly J, Parrish JA, Bloch KJ.
    Br J Dermatol; 1983 Apr; 108(4):445-50. PubMed ID: 6838768
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of psoriasis].
    Touraine R, Dubertret L.
    Rev Prat; 1978 Mar 11; 28(15):1163-73. PubMed ID: 653265
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V, Barbagallo T, Prestinari F, Rona C, De Silvestri A, Trevisan V, Borroni G.
    Int J Immunopathol Pharmacol; 2005 Mar 11; 18(4):755-60. PubMed ID: 16388725
    [Abstract] [Full Text] [Related]

  • 27. Effect of 8-methoxypsoralen plus UVA (PUVA) on lymphocyte transformation and T cells in psoriatic patients.
    Fräki JE, Eskola J, Hopsu-Havu VK.
    Br J Dermatol; 1979 May 11; 100(5):543-50. PubMed ID: 312653
    [No Abstract] [Full Text] [Related]

  • 28. Oral psoralen photochemotherapy of atopic eczema.
    Morison WL, Parrish J, Fitzpatrick TB.
    Br J Dermatol; 1978 Jan 11; 98(1):25-30. PubMed ID: 626712
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunological aspects of psoriasis. IV. Presence of circulating immune complexes in patients before and after PUVA therapy; correlations with T-cell markers.
    Guilhou JJ, Clot J, Guillot B, Andary M, Meynadier J.
    Br J Dermatol; 1980 Feb 11; 102(2):173-8. PubMed ID: 6966934
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Psoralen photochemotherapy.
    McClelland PB, Morgan P, Leach EE, Shelk J.
    Dermatol Nurs; 1997 Dec 11; 9(6):403-15; quiz 416-7. PubMed ID: 9460332
    [Abstract] [Full Text] [Related]

  • 34. Interaction of methotrexate and betamethasone with experimental phototoxic inflammation to PUVA (Psoralen and UVA) in mice.
    Ljunggren B, Möller H.
    Arch Dermatol Res; 1979 Mar 31; 264(2):257-60. PubMed ID: 464643
    [Abstract] [Full Text] [Related]

  • 35. Letter: Treatment of psoriasis with oral psoralens and longwave ultraviolet light.
    Reed WB.
    Acta Derm Venereol; 1976 Mar 31; 56(4):315-7. PubMed ID: 60032
    [No Abstract] [Full Text] [Related]

  • 36. Photochemotherapy (PUVA) in psoriasis.
    Benedetto AV, Roenigk HH.
    J Am Osteopath Assoc; 1976 Jun 31; 75(10):885-92. PubMed ID: 777077
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption.
    Alalaiwe A, Hung CF, Leu YL, Tahara K, Chen HH, Hu KY, Fang JY.
    Eur J Pharm Sci; 2018 Nov 01; 124():114-126. PubMed ID: 30153523
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Psoralens for psoriasis.
    Verbov J.
    Int J Dermatol; 1975 Nov 01; 14(9):649-50. PubMed ID: 1184256
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.